ClearBridge Investments’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
ClearBridge Investments's PCVX Position: Q3 2026 in Review
ClearBridge Investments increased its Vaxcyte (PCVX) stake by 9.6% in Q3 2026, buying an estimated $4.2M and bringing the position to 823,998 shares worth $46.9M. The position accounts for 0.04% of the portfolio, ranked #327.
ClearBridge Investments first reported a position in PCVX in Q2 2024 and has held it in 8 quarters since. The position peaked at $132M in Q3 2024. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- ClearBridge Investments held 823,998 shares of Vaxcyte worth $46.9M as of Q3 2026.
- ClearBridge Investments bought 71,999 Vaxcyte shares in Q3 2026, an estimated $4.2M.
- Vaxcyte made up 0.04% of ClearBridge Investments's portfolio in Q3 2026, its #327 holding.
- ClearBridge Investments first reported a position in Vaxcyte in Q2 2024 and has held it in 8 quarters since.
- ClearBridge Investments's Vaxcyte position peaked at $132M in Q3 2024.
- 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on ClearBridge Investments's 13F filing for Q3 2026, filed 12 Nov 2026.